论文部分内容阅读
目的 :观察生脉注射液对 4 8例原发性肝癌患者行经皮肝动脉化疗栓塞 (TAE)术后不良反应的疗效。方法 :两组均按Selding法行TAE术 ,对照组单用TAE术治疗 ,生脉组加生脉注射液治疗。结果 :用药 10～ 14d ,生脉组术后发热、乏力等症状较对照组轻 (P <0 .0 5) ,术后白细胞降低及谷 丙转氨酶 (ALT)升高幅度均较对照组小 (P <0 .0 5)。结论 :生脉注射液对TAE术具有较好的减毒增效作用。
Objective : To observe the effect of Shengmai injection on the adverse reactions after percutaneous transcatheter arterial chemoembolization (TAE) in 48 patients with primary liver cancer. Methods: TAE was performed according to Selding method in the two groups and TAE was used in the control group. Shengmai group was treated with Shengmai injection. RESULTS: After 10 to 14 days of medication, the symptoms of postoperative fever and fatigue in the Shengmai group were lighter than those in the control group (P < 0.05). The postoperative leukopenia and elevation of the alanine aminotransferase (ALT) were all lower than those in the control group ( P <0. 0 5). Conclusion: Shengmai injection has a good attenuated and synergistic effect on TAE.